Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 7 of 7 clinical reviews.
Evidence-based guide to amlodipine dosing in Black and African ancestry patients, including pharmacogenomic considerations, trial data from ALLHAT and ASCOT-BPLA, and clinical recommendations for optimizing blood pressure control.
Read clinical reviewEast Asian patients may need lower starting doses of amlodipine due to CYP3A5 polymorphisms, slower clearance, and higher plasma exposure. This guide covers the pharmacogenomic evidence, dosing recommendations, and clinical considerations for East Asian populations.
Read clinical reviewHow does amlodipine behave differently in Hispanic and Latino patients? This evidence-based guide covers pharmacogenomics, CYP3A5 variants, ethnicity-stratified trial data, dosing considerations, and diabetes-related safety signals specific to Hispanic and Latino populations.
Read clinical reviewEvidence-based review of amlodipine efficacy in Black and African ancestry patients, including ALLHAT and ASCOT-BPLA trial data, pharmacogenomic considerations, and guideline-directed dosing.
Read clinical reviewEast Asian patients often reach higher amlodipine blood levels at standard doses due to CYP3A4/3A5 polymorphisms and lower average body weight. Learn how pharmacogenomics, clinical trials, and guideline recommendations shape safer prescribing for this population.
Read clinical reviewA comprehensive clinical review of amlodipine efficacy differences in Hispanic and Latino patients, covering pharmacogenomics, CYP3A4/5 variants, ethnicity-stratified trial data, and dosing considerations for this population.
Read clinical reviewDo South Asian patients need different amlodipine doses? This clinically detailed guide covers pharmacogenomics, ethnicity-stratified trial data, and practical dosing guidance for South Asian adults with hypertension.
Read clinical review